Cinnamaldehyde Enhances Antimelanoma Activity through Covalently Binding ENO1 and Exhibits a Promoting Effect with Dacarbazine
Open Access
- 29 January 2020
- Vol. 12 (2), 311
- https://doi.org/10.3390/cancers12020311
Abstract
At present, melanoma is a common malignant tumor with the highest mortality rate of all types of skin cancer. Although the first option for treating melanoma is with chemicals, the effects are unsatisfactory and include poor medication response and high resistance. Therefore, developing new medicines or a novel combination approach would be a significant breakthrough. Here, we present cinnamaldehyde (CA) as a potential candidate, which exerted an antitumor effect in melanoma cell lines. Chemical biology methods of target fishing, molecular imaging, and live cell tracing by an alkynyl–CA probe revealed that the α-enolase (ENO1) protein was the target of CA. The covalent binding of CA with ENO1 changed the stability of the ENO1 protein and affected the glycolytic activity. Furthermore, our results demonstrated that dacarbazine (DTIC) showed a high promoting effect with CA for antimelanoma both in vivo and in vitro. The combination improved the DTIC cell cycle arrest in the S phase and markedly impacted melanoma growth. As a covalent inhibitor of ENO1, CA combined with DTIC may be beneficial in patients with drug resistance in antimelanoma therapy.This publication has 57 references indexed in Scilit:
- Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresisMutation Research/Genetic Toxicology and Environmental Mutagenesis, 2011
- Searching for synthetic lethality in cancerCurrent Opinion in Genetics & Development, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cellsBreast Cancer Research and Treatment, 2009
- The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growthFree Radical Biology & Medicine, 2009
- Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53British Journal of Cancer, 2009
- Combination chemical geneticsNature Chemical Biology, 2008
- Suppression of age-related inflammatory NF-κB activation by cinnamaldehydeBiogerontology, 2007
- Combined treatment with Ad‐hTRAIL and DTIC or SAHA is associated with increased mitochondrial‐mediated apoptosis in human melanoma cell linesThe Journal of Gene Medicine, 2007
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005